Takeda Pharmaceutical Co (JP:4502) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Takeda Pharmaceutical Co. has released its audited consolidated financial statements for the fiscal years ending March 31, 2023, and 2024, in accordance with International Financial Reporting Standards. The report covers the company’s performance and includes financial details represented in American Depositary Shares and Receipts. All amounts are rounded to the nearest digit for ease of interpretation.
For further insights into JP:4502 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue